1-3 of 3
Christian Kuhn, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab Maintenenance Therapy Prolongs Event Free Survival in Patients with CD20+ B-Cell Non-Hodgkin-Lymphoma.

Mathias Witzens-Harig, MD, Manfred Hensel, MD, Johann W. Schmier, MD, Kai Neben, MD, Axel Benner, PhD, Peter Dreger, MD, Christian Kuhn, MD, Ingo Schmidt-Wolf, MD, Alwin Kraemer, MD, Anthony D. Ho, MD
Journal: Blood
Blood (2007) 110 (11): 4472.
https://doi.org/10.1182/blood.V110.11.4472.4472
Published: 2007
Journal Articles

Serum Levels and Pharmacokinetic of Rituximab in Bi-Weekly R-CHOP in Elderly Patients with DLBCL Treated in the RICOVER-60 Trial.

Marcel Reiser, MD, Michael K. Wenger, MD, Christina Nickenig, MD, N. Peter, MD, Christian Kuhn, MD, Bernd Metzner, MD, Martin Theisohn, MD, Michael Pfreundschuh, MD
Journal: Blood
Blood (2006) 108 (11): 2748.
https://doi.org/10.1182/blood.V108.11.2748.2748
Published: 2006
Journal Articles

Rituximab Maintenenance Therapy in CD20+ B-Cell Non-Hodgkin-Lymphoma - Results of a Multicenter Prospective Randomised Phase II Study.

Mathias Witzens-Harig, MD, Manfred Hensel, MD, Johann W. Schmier, MD, Kai Neben, MD, Axel Benner, PhD, Peter Dreger, MD, Christian Kuhn, MD, Ingo Schmidt-Wolf, MD, Alwin Krämer, MD, Anthony D. Ho, MD
Journal: Blood
Blood (2006) 108 (11): 4704.
https://doi.org/10.1182/blood.V108.11.4704.4704
Published: 2006